DGKalpha-IN-2 (example 48) is a DGKalpha inhibitor with the IC50 of 0.9 nM, extracted from patent WO2021105115. DGKalpha-IN-2 significantly enhances the anti-tumor effect of anti-PD-1 by increasing the proliferation and function of T cells. DGKalpha-IN-2 has the potential for cancer and immunology study.
Molekulargewicht:
461.43
Reinheit:
98.83
CAS Nummer:
[2648556-92-5]
Formel:
C23H22F3N3O4
Target-Kategorie:
Anaplastic lymphoma kinase (ALK),DGK
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten